Darvocet /00220901/


Combined with:

Darvon
Darvon /00018802/
Propoxyphene Hydrochloride And Acetaminophen
Propoxyphene Hydrochloride/Acetaminophen 65/650 (Watson Laboratories)

Indications and Reactions:

Role Indications Reactions
Secondary
Pain Management 87.4%
Pain 9.6%
Analgesia 2.4%
Product Used For Unknown Indication 0.3%
Diabetes Mellitus 0.1%
Headache 0.1%
Migraine 0.1%
Back Pain 0.0%
Myalgia 0.0%
Neck Pain 0.0%
Cardiac Disorder 73.7%
Cardiovascular Disorder 15.8%
Multiple Injuries 2.5%
Myocardial Infarction 1.6%
Tachycardia 1.3%
Heart Rate Irregular 1.1%
Supraventricular Tachycardia 0.7%
Cardiac Pacemaker Insertion 0.7%
Syncope 0.5%
Ventricular Fibrillation 0.4%
Electrocardiogram Qt Prolonged 0.3%
Heart Injury 0.3%
Arrhythmia 0.2%
Ventricular Tachycardia 0.2%
Injury 0.1%
Ventricular Extrasystoles 0.1%
Cardiac Failure 0.1%
Cardio-respiratory Arrest 0.1%
Cardiomyopathy 0.1%
Cerebrovascular Accident 0.1%
Concomitant
Product Used For Unknown Indication 15.4%
Hypertension 9.9%
Pain 9.5%
Diabetes Mellitus 8.4%
Prophylaxis Against Transplant Rejection 7.7%
Drug Use For Unknown Indication 5.5%
Type 2 Diabetes Mellitus 5.1%
Supplementation Therapy 4.4%
Mineral Supplementation 4.0%
Arthritis 3.7%
Neuropathy Peripheral 3.7%
Scan 3.7%
Blood Cholesterol 3.3%
Nuclear Magnetic Resonance Imaging 2.9%
Sleep Disorder 2.9%
Osteoporosis 2.2%
Vitamin Supplementation 2.2%
Back Pain 1.8%
Energy Increased 1.8%
Nervousness 1.8%
Vomiting 14.3%
Weight Decreased 9.5%
Nausea 7.1%
Road Traffic Accident 7.1%
Transplant Failure 7.1%
White Blood Cell Count Increased 7.1%
Drug Ineffective 4.8%
Renal Failure Chronic 4.8%
Somnolence 4.8%
Urinary Incontinence 4.8%
Vertigo 4.8%
Weight Increased 4.8%
Blood Cholesterol Increased 2.4%
Chest Pain 2.4%
Haemoglobin Decreased 2.4%
Hypertension 2.4%
Knee Arthroplasty 2.4%
Ligament Rupture 2.4%
Nephrogenic Systemic Fibrosis 2.4%
Off Label Use 2.4%

Drug Data